期刊文献+

多潘立酮胃内滞留型缓释片的制备 被引量:13

Preparation of Domperidone Sustained-Release Floating Tablets
下载PDF
导出
摘要 目的 :研制多潘立酮胃内滞留型缓释片 ,建立HPLC法测定多潘立酮胃内滞留型缓释片有关物质的方法。方法 :以羟丙甲纤维素和卡波姆为主要凝胶材料制备片剂 ,考察释放度和漂浮性 ;采用HypersilODS2柱 ,甲醇 - 5g/L的乙酸铵溶液 三乙胺为流动相 ,流速为 1ml/min ,检测波长为 2 85nm。结果 :多潘立酮胃内滞留型缓释片具有较好的漂浮和缓释效果。多潘立酮的最低检测浓度为 2 3 76ng/ml,有关物质可检出杂质 4个。结论 :本研究制备的多潘立酮胃内滞留型缓释片具有起漂时间快、缓释的特点 ;有关物质检查方法简单、快速、结果准确。 AIM:To prepare domperidone sustained-release floating tablets and establish a method for isolation and determination of related substances. METHOD:The tablets were prepared by the use of HPMC and Carbopol as gel matrix. In vitro release rate and floating capability were observed to evaluate the formulation; HPLC is adopted using Hypersil ODS_ 2 column, the mobile phase is methanol-5 g/L ammonium acetate solution-triethylamine, and its mobile rate is 1 ml/min, with detective wavelength of 285 nm. RESULT:The floating capability of domperidone sustained-release floating tablets is good and the formulation could ensure the desired in vitro release rate. The detective limit of domperidone was 23.76 ng/ml, 4 related substances were determined. CONCLUTION:The tablets prepared can achieve sustained release with short floating lagtime; The method of determining related substances was simple, sensitive, and accurate.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2003年第4期327-329,共3页 Journal of China Pharmaceutical University
关键词 多潘立酮 胃内滞留型缓释片 释放度 漂浮 高效液相色谱法 Domperidone Sustained-release floating tablet Release Floating HPLC
  • 相关文献

参考文献5

  • 1Joseph A. Barone. Domperidone: Mechanism of action and clinical use[J].Hospital Pharmacy,1998,33(2):191-197. 被引量:1
  • 2陈寿坡主编..胃肠病临床药理学[M].北京:科学出版社,1998:664.
  • 3Heykants J, Hendriks R, Meuldermans W,et al.On the pharma-cokinetics of domperidone in animals and man Ⅳ.The pharmacohinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral, and rectal administration[J]. European Journal of Drug Metabolism and Phamacokinetics,1981,6(1):61-70. 被引量:1
  • 4Joseph A. Barone.Domperidone: A peripherally acting dopamine2-receptor antagonist[J]. The Annals of Pharmacotherapy,1999,33:429-440. 被引量:1
  • 5Nagarsenker MS, Garad SD, Ramprakash G.Design, optimization and evaluation of domperidone coevaporates[J]. Journal of Controlled Release,2001,63:31-39. 被引量:1

同被引文献116

引证文献13

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部